Show simple item record

dc.contributor.authorBorràs, Mercè
dc.contributor.authorPérez Fontán, Miguel
dc.contributor.authorMartínez Alonso, Montserrat
dc.contributor.authorBajo, Auxiliadora
dc.contributor.authorBetriu i Bars, M. Àngels
dc.contributor.authorValdivielso Revilla, José Manuel
dc.contributor.authorFernández i Giráldez, Elvira
dc.date.accessioned2018-01-09T11:33:57Z
dc.date.available2018-01-09T11:33:57Z
dc.date.issued2017
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10459.1/62313
dc.description.abstractThere is limited and inconclusive information regarding the influence of the modality of renal replacement therapy on the atherosclerotic burden of patients on dialysis. The aim of this study was to compare the prevalence of asymptomatic atheromatous carotid disease, as also its rate of progression and cardiovascular outcomes, in two matched populations of patients treated with hemodialysis (HD) and peritoneal dialysis (PD).ca_ES
dc.description.sponsorshipThe NEFRONA study is funded by a research grant from AbbVie.ca_ES
dc.language.isoengca_ES
dc.publisherPublic Library of Scienceca_ES
dc.relation.isformatofReproducció del document publicat a https://doi.org/10.1371/journal.pone.0186921ca_ES
dc.relation.ispartofPlos One, 2017, vol. 12, núm. 11, p. 1-16ca_ES
dc.relation.isreferencedbyhttp://hdl.handle.net/10459.1/65137
dc.rightscc-by (c) Borràs et al., 2017ca_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.titleThe modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular diseaseca_ES
dc.typearticleca_ES
dc.identifier.idgrec026127
dc.type.versionpublishedVersionca_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca_ES
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0186921


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

cc-by (c) Borràs et al., 2017
Except where otherwise noted, this item's license is described as cc-by (c) Borràs et al., 2017